Patients are at the core of our thinking and we make sure that our efforts do not end with developing a new product or therapy, but extend beyond to provide a holistic solution to the patients. Our innovation program focuses some of the toughest t health care challenges including AMR and oncology. We are working relentlessly towards our aim of possibilities to patients so as to reduce their sufferings by providing better solutions for unmet medical needs.
The alarming trend in the rise of resistance to existing antibiotics and the downturn in the development of new antibiotics will lead to the catastrophe of not being able to treat common infections effectively. The research team at Venus Remedies Limited realized the need for effective
Another key focus area of research is Cancer diagnostic and therapeutics . Scientists at VMRC are working on target-based drug delivery for cancer treatment and designed a platform technology with a novel concept of triple conjugate i.e., Drug-Protein-Polymer-Conjugate (DPPC) for the purpose.
Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to VRL India, its subsidiaries or affiliates. No use of any VRL India trademark, trade name, or trade dress in this site may be made without the prior written authorization of VRL India, except to identify the product or services of the company.